Quantbot Technologies
TRVI icon

Quantbot Technologies’s Trevi Therapeutics TRVI Stock Holding History

Quantbot Technologies’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.69M Buy
+117,935
New +$2.03M 0.06% 502
2025
Q2 		– Sell
-1,051
Closed -$6.61K – 1959
2025
Q1 		$6.61K Buy
+1,051
New +$5.01K ﹤0.01% 1393

Other funds holding TRVI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vivo Capital
Vivo Capital Palo Alto, California $909M AUM 385.65% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.14B AUM 65.02% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Quantbot Technologies's TRVI Position: Q3 2026 in Review

Quantbot Technologies opened a new position in Trevi Therapeutics (TRVI) in Q3 2026: 117,935 shares worth $1.69M. The stake represents 0.06% of the portfolio and ranks #502 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in TRVI as recently as Q1 2025.

Quantbot Technologies first reported a position in TRVI in Q1 2025 and has held it in 2 quarters since. 152 funds tracked by Wall St. Rank hold TRVI as of Q3 2026.

  • Quantbot Technologies held 117,935 shares of Trevi Therapeutics worth $1.69M as of Q3 2026.
  • Trevi Therapeutics was a new Quantbot Technologies position in Q3 2026.
  • Trevi Therapeutics made up 0.06% of Quantbot Technologies's portfolio in Q3 2026, its #502 holding.
  • Quantbot Technologies first reported a position in Trevi Therapeutics in Q1 2025 and has held it in 2 quarters since.
  • 152 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q3 2026.

Based on Quantbot Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.